ReP USP - Resultado da busca

Curadoria
Brazilian Symposium on Medicinal Chemistry -BrazMedChem, 12 (2025)
Oliva, Glaucius (cur) ; Guido, Rafael Victorio Carvalho (cur) ; Leitão, Andrei (cur) ; Emery, Flavio da Silva (cur) ; Trossini, Gustavo Henrique Goulart (cur) ; Nonato, Maria Cristina (cur) ; Valli, Marilia (cur)
Unidades: IFSC, IQSC, FCFRP, FCF
Subjects: QUÍMICA MÉDICA, EVENTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
Brazilian Symposium on Medicinal Chemistry -BrazMedChem, 12. . Rio de Janeiro: Universidade Federal do Rio de Janeiro - UFRJ. Disponível em: https://repositorio.usp.br/directbitstream/f55ceb5a-e6d4-4d58-b6fb-432e83cf9927/3277219.pdf. Acesso em: 27 nov. 2025. , 2025
APA
Brazilian Symposium on Medicinal Chemistry -BrazMedChem, 12. (2025). Brazilian Symposium on Medicinal Chemistry -BrazMedChem, 12. Rio de Janeiro: Universidade Federal do Rio de Janeiro - UFRJ. Recuperado de https://repositorio.usp.br/directbitstream/f55ceb5a-e6d4-4d58-b6fb-432e83cf9927/3277219.pdf
NLM
Brazilian Symposium on Medicinal Chemistry -BrazMedChem, 12 [Internet]. 2025 ;[citado 2025 nov. 27 ] Available from: https://repositorio.usp.br/directbitstream/f55ceb5a-e6d4-4d58-b6fb-432e83cf9927/3277219.pdf
Vancouver
Brazilian Symposium on Medicinal Chemistry -BrazMedChem, 12 [Internet]. 2025 ;[citado 2025 nov. 27 ] Available from: https://repositorio.usp.br/directbitstream/f55ceb5a-e6d4-4d58-b6fb-432e83cf9927/3277219.pdf
Artigo de periodico
Advances and challenges in molecular docking applied to neglected tropical diseases (2025)
Angelo, Rafaela Molina de ; Nascimento, Lucas Alex; Encide, João Pedro Portilho; Silva, Henrique Borges da ; Lago, João Henrique Ghilardi ; Emery, Flavio da Silva ; Honorio, Kathia Maria
Source: Current Medicinal Chemistry. Unidades: FCFRP, EACH
Assunto: DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANGELO, Rafaela Molina de et al. Advances and challenges in molecular docking applied to neglected tropical diseases. Current Medicinal Chemistry, n. Ja 2025, p. 01-21, 2025Tradução . . Disponível em: http://dx.doi.org/10.2174/0109298673327352240930040103. Acesso em: 27 nov. 2025.
APA
Angelo, R. M. de, Nascimento, L. A., Encide, J. P. P., Silva, H. B. da, Lago, J. H. G., Emery, F. da S., & Honorio, K. M. (2025). Advances and challenges in molecular docking applied to neglected tropical diseases. Current Medicinal Chemistry, ( Ja 2025), 01-21. doi:10.2174/0109298673327352240930040103
NLM
Angelo RM de, Nascimento LA, Encide JPP, Silva HB da, Lago JHG, Emery F da S, Honorio KM. Advances and challenges in molecular docking applied to neglected tropical diseases [Internet]. Current Medicinal Chemistry. 2025 ;( Ja 2025): 01-21.[citado 2025 nov. 27 ] Available from: http://dx.doi.org/10.2174/0109298673327352240930040103
Vancouver
Angelo RM de, Nascimento LA, Encide JPP, Silva HB da, Lago JHG, Emery F da S, Honorio KM. Advances and challenges in molecular docking applied to neglected tropical diseases [Internet]. Current Medicinal Chemistry. 2025 ;( Ja 2025): 01-21.[citado 2025 nov. 27 ] Available from: http://dx.doi.org/10.2174/0109298673327352240930040103
Artigo de periodico
Fragment screening reveals novel scaffolds against sirtuin-2-related Protein 1 from Trypanosoma brucei (2025)
Gomes, Renan Augusto; Polêto, Marcelo Depólo; Verli, Hugo ; Almeida, Vitor Medeiros ; Marana, Sandro Roberto ; Bender, Andreas ; Godoi, Bruna Fleck; Rodrigues, Vinícius T. L; Emery, Flavio da Silva ; Trossini, Gustavo Henrique Goulart
Source: ACS Omega. Unidades: IQ, FCFRP, FCF
Subjects: TRYPANOSOMA, LIGANTES, PEPTÍDEOS, PROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Renan Augusto et al. Fragment screening reveals novel scaffolds against sirtuin-2-related Protein 1 from Trypanosoma brucei. ACS Omega, v. 10, n. 4, p. 3808–3819, 2025Tradução . . Disponível em: https://dx.doi.org/10.1021/acsomega.4c09231. Acesso em: 27 nov. 2025.
APA
Gomes, R. A., Polêto, M. D., Verli, H., Almeida, V. M., Marana, S. R., Bender, A., et al. (2025). Fragment screening reveals novel scaffolds against sirtuin-2-related Protein 1 from Trypanosoma brucei. ACS Omega, 10( 4), 3808–3819. doi:10.1021/acsomega.4c09231
NLM
Gomes RA, Polêto MD, Verli H, Almeida VM, Marana SR, Bender A, Godoi BF, Rodrigues VTL, Emery F da S, Trossini GHG. Fragment screening reveals novel scaffolds against sirtuin-2-related Protein 1 from Trypanosoma brucei [Internet]. ACS Omega. 2025 ; 10( 4): 3808–3819.[citado 2025 nov. 27 ] Available from: https://dx.doi.org/10.1021/acsomega.4c09231
Vancouver
Gomes RA, Polêto MD, Verli H, Almeida VM, Marana SR, Bender A, Godoi BF, Rodrigues VTL, Emery F da S, Trossini GHG. Fragment screening reveals novel scaffolds against sirtuin-2-related Protein 1 from Trypanosoma brucei [Internet]. ACS Omega. 2025 ; 10( 4): 3808–3819.[citado 2025 nov. 27 ] Available from: https://dx.doi.org/10.1021/acsomega.4c09231
Trabalho de evento-resumo
Using a fragment-based approach against a potential novel drug target in Mycobacterium tuberculosis (2025)
Silva, Catharina dos Santos ; Rodrigues, Vinícius Lopes Tarouquella; Libreros-Zunigã, Gerardo Andrés; Rossini, Nicolas de Oliveira ; Guterrez, Kevim; Barroso, Vinícius de Morais ; Mesquita, Nathalya Cristina de Moraes Roso ; Tinoco, Luzineide; Sforça, Maurício Luis; Guimarães, Ana Marcia de Sá ; Ishida, Kelly ; Emery, Flavio da Silva ; Dias, Marcio Vinicius Bertacine
Source: Livro de Resumos. Conference titles: Annual Meeting of the Brazilian Society for Biochemistry and Molecular Biology - SBBq. Unidades: ICB, FCFRP, IFSC
Subjects: TUBERCULOSE, PLANEJAMENTO DE FÁRMACOS, RESSONÂNCIA MAGNÉTICA NUCLEAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Catharina dos Santos et al. Using a fragment-based approach against a potential novel drug target in Mycobacterium tuberculosis. 2025, Anais.. São Paulo: Sociedade Brasileira de Bioquímica e Biologia Molecular - SBBq, 2025. Disponível em: https://www2.sbbq.org.br/reuniao/2025/images/resumos.pdf. Acesso em: 27 nov. 2025.
APA
Silva, C. dos S., Rodrigues, V. L. T., Libreros-Zunigã, G. A., Rossini, N. de O., Guterrez, K., Barroso, V. de M., et al. (2025). Using a fragment-based approach against a potential novel drug target in Mycobacterium tuberculosis. In Livro de Resumos. São Paulo: Sociedade Brasileira de Bioquímica e Biologia Molecular - SBBq. Recuperado de https://www2.sbbq.org.br/reuniao/2025/images/resumos.pdf
NLM
Silva C dos S, Rodrigues VLT, Libreros-Zunigã GA, Rossini N de O, Guterrez K, Barroso V de M, Mesquita NC de MR, Tinoco L, Sforça ML, Guimarães AM de S, Ishida K, Emery F da S, Dias MVB. Using a fragment-based approach against a potential novel drug target in Mycobacterium tuberculosis [Internet]. Livro de Resumos. 2025 ;[citado 2025 nov. 27 ] Available from: https://www2.sbbq.org.br/reuniao/2025/images/resumos.pdf
Vancouver
Silva C dos S, Rodrigues VLT, Libreros-Zunigã GA, Rossini N de O, Guterrez K, Barroso V de M, Mesquita NC de MR, Tinoco L, Sforça ML, Guimarães AM de S, Ishida K, Emery F da S, Dias MVB. Using a fragment-based approach against a potential novel drug target in Mycobacterium tuberculosis [Internet]. Livro de Resumos. 2025 ;[citado 2025 nov. 27 ] Available from: https://www2.sbbq.org.br/reuniao/2025/images/resumos.pdf
Artigo de periodico
SETDB1 as a cancer target: challenges and perspectives in drug design (2024)
Hassanie, Haifa ; Penteado, André Berndt ; Almeida, Larissa Costa de ; Calil, Raisa Ludmila; Emery, Flavio da Silva ; Costa-Lotufo, Letícia Veras ; Trossini, Gustavo Henrique Goulart
Source: RSC Medicinal Chemistry. Unidades: FCFRP, ICB, FCF
Subjects: NEOPLASIAS, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HASSANIE, Haifa et al. SETDB1 as a cancer target: challenges and perspectives in drug design. RSC Medicinal Chemistry, v. 15, n. 5, p. 1424-1451, 2024Tradução . . Disponível em: https://dx.doi.org/10.1039/D3MD00366C. Acesso em: 27 nov. 2025.
APA
Hassanie, H., Penteado, A. B., Almeida, L. C. de, Calil, R. L., Emery, F. da S., Costa-Lotufo, L. V., & Trossini, G. H. G. (2024). SETDB1 as a cancer target: challenges and perspectives in drug design. RSC Medicinal Chemistry, 15( 5), 1424-1451. doi:10.1039/D3MD00366C
NLM
Hassanie H, Penteado AB, Almeida LC de, Calil RL, Emery F da S, Costa-Lotufo LV, Trossini GHG. SETDB1 as a cancer target: challenges and perspectives in drug design [Internet]. RSC Medicinal Chemistry. 2024 ; 15( 5): 1424-1451.[citado 2025 nov. 27 ] Available from: https://dx.doi.org/10.1039/D3MD00366C
Vancouver
Hassanie H, Penteado AB, Almeida LC de, Calil RL, Emery F da S, Costa-Lotufo LV, Trossini GHG. SETDB1 as a cancer target: challenges and perspectives in drug design [Internet]. RSC Medicinal Chemistry. 2024 ; 15( 5): 1424-1451.[citado 2025 nov. 27 ] Available from: https://dx.doi.org/10.1039/D3MD00366C
Curadoria
Brazilian Symposium on Medicinal Chemistry - BrazMedChem, 11 (2023)
Andricopulo, Adriano Defini (cur) ; Trossini, Gustavo Henrique Goulart (cur) ; Nonato, Maria Cristina (cur) ; Nascimento, Alessandro Silva (cur) ; Emery, Flavio da Silva (cur) ; Dias, Marcio Vinicius Bertacine (cur) ; Parise Filho, Roberto (cur)
Unidades: IFSC, FCF, FCFRP, ICB
Subjects: CRISTALOGRAFIA, QUÍMICA MÉDICA, PESQUISA CIENTÍFICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
Brazilian Symposium on Medicinal Chemistry - BrazMedChem, 11. . Salvador: Universidade Federal da Bahia - UFBA. . Acesso em: 27 nov. 2025. , 2023
APA
Brazilian Symposium on Medicinal Chemistry - BrazMedChem, 11. (2023). Brazilian Symposium on Medicinal Chemistry - BrazMedChem, 11. Salvador: Universidade Federal da Bahia - UFBA.
NLM
Brazilian Symposium on Medicinal Chemistry - BrazMedChem, 11. 2023 ;[citado 2025 nov. 27 ]
Vancouver
Brazilian Symposium on Medicinal Chemistry - BrazMedChem, 11. 2023 ;[citado 2025 nov. 27 ]
Artigo de periodico
Human sirtuin 2 inhibitors, their mechanisms and binding modes (2023)
Penteado, André Berndt ; Hassanie, Haifa ; Gomes, Renan Augusto ; Emery, Flavio da Silva ; Trossini, Gustavo Henrique Goulart
Source: Future Medicinal Chemistry. Unidades: FCFRP, FCF
Subjects: METABOLISMO, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PENTEADO, André Berndt et al. Human sirtuin 2 inhibitors, their mechanisms and binding modes. Future Medicinal Chemistry, v. 15, n. 3, p. 291-311, 2023Tradução . . Disponível em: https://doi.org/10.4155/fmc-2022-0253. Acesso em: 27 nov. 2025.
APA
Penteado, A. B., Hassanie, H., Gomes, R. A., Emery, F. da S., & Trossini, G. H. G. (2023). Human sirtuin 2 inhibitors, their mechanisms and binding modes. Future Medicinal Chemistry, 15( 3), 291-311. doi:10.4155/fmc-2022-0253
NLM
Penteado AB, Hassanie H, Gomes RA, Emery F da S, Trossini GHG. Human sirtuin 2 inhibitors, their mechanisms and binding modes [Internet]. Future Medicinal Chemistry. 2023 ; 15( 3): 291-311.[citado 2025 nov. 27 ] Available from: https://doi.org/10.4155/fmc-2022-0253
Vancouver
Penteado AB, Hassanie H, Gomes RA, Emery F da S, Trossini GHG. Human sirtuin 2 inhibitors, their mechanisms and binding modes [Internet]. Future Medicinal Chemistry. 2023 ; 15( 3): 291-311.[citado 2025 nov. 27 ] Available from: https://doi.org/10.4155/fmc-2022-0253
Artigo de periodico
Synthesis and vectorial functionalisation of pyrazolo[3,4-c]pyridines (2023)
Bedwell, Elizabeth V.; Emery, Flavio da Silva ; Clososki, Giuliano Cesar ; Steel, Patrick G.
Source: RSC Advances. Unidade: FCFRP
Subjects: FÁRMACOS, ÁTOMOS, ELETRÓLITOS, QUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BEDWELL, Elizabeth V. et al. Synthesis and vectorial functionalisation of pyrazolo[3,4-c]pyridines. RSC Advances, v. 13, n. 49, p. 34391-34399, 2023Tradução . . Disponível em: https://doi.org/10.1039/D3RA07458G. Acesso em: 27 nov. 2025.
APA
Bedwell, E. V., Emery, F. da S., Clososki, G. C., & Steel, P. G. (2023). Synthesis and vectorial functionalisation of pyrazolo[3,4-c]pyridines. RSC Advances, 13( 49), 34391-34399. doi:10.1039/D3RA07458G
NLM
Bedwell EV, Emery F da S, Clososki GC, Steel PG. Synthesis and vectorial functionalisation of pyrazolo[3,4-c]pyridines [Internet]. RSC Advances. 2023 ; 13( 49): 34391-34399.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1039/D3RA07458G
Vancouver
Bedwell EV, Emery F da S, Clososki GC, Steel PG. Synthesis and vectorial functionalisation of pyrazolo[3,4-c]pyridines [Internet]. RSC Advances. 2023 ; 13( 49): 34391-34399.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1039/D3RA07458G
Artigo de periodico
Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design (2023)
Ferreira, Glaucio Monteiro ; Kronenberger, Thales ; Maltarollo, Vinícius Gonçalves ; Poso, Antti ; Gatti, Fernando de Moura ; Almeida, Vitor Medeiros ; Marana, Sandro Roberto ; Lopes, Carla Duque ; Tezuka, Daiane Yukie; Albuquerque, Sérgio de ; Emery, Flavio da Silva ; Trossini, Gustavo Henrique Goulart
Source: Pharmaceuticals. Unidades: FCF, IQ, FCFRP
Subjects: TRYPANOSOMA CRUZI, ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Glaucio Monteiro et al. Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design. Pharmaceuticals, v. 16 , p. 1-14 art. 428, 2023Tradução . . Disponível em: https://doi.org/10.3390/ph16030428. Acesso em: 27 nov. 2025.
APA
Ferreira, G. M., Kronenberger, T., Maltarollo, V. G., Poso, A., Gatti, F. de M., Almeida, V. M., et al. (2023). Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design. Pharmaceuticals, 16 , 1-14 art. 428. doi:10.3390/ph16030428
NLM
Ferreira GM, Kronenberger T, Maltarollo VG, Poso A, Gatti F de M, Almeida VM, Marana SR, Lopes CD, Tezuka DY, Albuquerque S de, Emery F da S, Trossini GHG. Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design [Internet]. Pharmaceuticals. 2023 ; 16 1-14 art. 428.[citado 2025 nov. 27 ] Available from: https://doi.org/10.3390/ph16030428
Vancouver
Ferreira GM, Kronenberger T, Maltarollo VG, Poso A, Gatti F de M, Almeida VM, Marana SR, Lopes CD, Tezuka DY, Albuquerque S de, Emery F da S, Trossini GHG. Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design [Internet]. Pharmaceuticals. 2023 ; 16 1-14 art. 428.[citado 2025 nov. 27 ] Available from: https://doi.org/10.3390/ph16030428
Curadoria
Brazilian Symposium on Medicinal Chemistry - BrazMedChem (2022)
Guido, Rafael Victorio Carvalho (cur) ; Emery, Flavio da Silva (cur)
Unidades: IFSC, FCFRP
Subjects: CRISTALOGRAFIA, QUÍMICA MÉDICA, PESQUISA CIENTÍFICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
Brazilian Symposium on Medicinal Chemistry - BrazMedChem. . Campinas: Galoá. . Acesso em: 27 nov. 2025. , 2022
APA
Brazilian Symposium on Medicinal Chemistry - BrazMedChem. (2022). Brazilian Symposium on Medicinal Chemistry - BrazMedChem. Campinas: Galoá.
NLM
Brazilian Symposium on Medicinal Chemistry - BrazMedChem. 2022 ;[citado 2025 nov. 27 ]
Vancouver
Brazilian Symposium on Medicinal Chemistry - BrazMedChem. 2022 ;[citado 2025 nov. 27 ]
Artigo de periodico
2-Imidazolidinone benzofurans as unexpected outcome of the Lewis acid mediated Nenitzescu reaction (2022)
Horsten, Tomas; Price, Temitayo Omowumi Alegbejo ; Van Meervelt, Luc; Emery, Flavio da Silva ; Dehaen, Wim
Source: New Journal of Chemistry. Unidade: FCFRP
Subjects: SÍNTESE QUÍMICA, BENZENO, COMPOSTOS CÍCLICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HORSTEN, Tomas et al. 2-Imidazolidinone benzofurans as unexpected outcome of the Lewis acid mediated Nenitzescu reaction. New Journal of Chemistry, v. 46, n. 5, p. 2028-2032, 2022Tradução . . Disponível em: https://doi.org/10.1039/d1nj04965h. Acesso em: 27 nov. 2025.
APA
Horsten, T., Price, T. O. A., Van Meervelt, L., Emery, F. da S., & Dehaen, W. (2022). 2-Imidazolidinone benzofurans as unexpected outcome of the Lewis acid mediated Nenitzescu reaction. New Journal of Chemistry, 46( 5), 2028-2032. doi:10.1039/d1nj04965h
NLM
Horsten T, Price TOA, Van Meervelt L, Emery F da S, Dehaen W. 2-Imidazolidinone benzofurans as unexpected outcome of the Lewis acid mediated Nenitzescu reaction [Internet]. New Journal of Chemistry. 2022 ; 46( 5): 2028-2032.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1039/d1nj04965h
Vancouver
Horsten T, Price TOA, Van Meervelt L, Emery F da S, Dehaen W. 2-Imidazolidinone benzofurans as unexpected outcome of the Lewis acid mediated Nenitzescu reaction [Internet]. New Journal of Chemistry. 2022 ; 46( 5): 2028-2032.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1039/d1nj04965h
Artigo de periodico
From hit seeking to magic bullets: the successful union of epigenetic and fragment based drug discovery (EPIDD + FBDD) (2021)
Vaidergorn, Miguel M.; da Silva Emery, Flavio; Ganesan, A.
Source: Journal of Medicinal Chemistry. Unidade: FCFRP
Subjects: LIGANTES, ESTRUTURA MOLECULAR (QUÍMICA TEÓRICA), SULFONAMIDAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VAIDERGORN, Miguel M. e DA SILVA EMERY, Flavio e GANESAN, A. From hit seeking to magic bullets: the successful union of epigenetic and fragment based drug discovery (EPIDD + FBDD). Journal of Medicinal Chemistry, v. 64, n. 19, p. 13980-14010, 2021Tradução . . Disponível em: https://doi.org/10.1021/acs.jmedchem.1c00787. Acesso em: 27 nov. 2025.
APA
Vaidergorn, M. M., da Silva Emery, F., & Ganesan, A. (2021). From hit seeking to magic bullets: the successful union of epigenetic and fragment based drug discovery (EPIDD + FBDD). Journal of Medicinal Chemistry, 64( 19), 13980-14010. doi:10.1021/acs.jmedchem.1c00787
NLM
Vaidergorn MM, da Silva Emery F, Ganesan A. From hit seeking to magic bullets: the successful union of epigenetic and fragment based drug discovery (EPIDD + FBDD) [Internet]. Journal of Medicinal Chemistry. 2021 ; 64( 19): 13980-14010.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1021/acs.jmedchem.1c00787
Vancouver
Vaidergorn MM, da Silva Emery F, Ganesan A. From hit seeking to magic bullets: the successful union of epigenetic and fragment based drug discovery (EPIDD + FBDD) [Internet]. Journal of Medicinal Chemistry. 2021 ; 64( 19): 13980-14010.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1021/acs.jmedchem.1c00787
Artigo de periodico
Docetaxel-loaded folate-modified TPGS-transfersomes for glioblastoma multiforme treatment (2021)
Luiz, Marcela Tavares ; Viegas, Juliana Santos Rosa ; Abriata, Juliana Palma ; Tofani, Larissa Bueno ; Vaidergorn, Miguel de Menezes ; Emery, Flavio da Silva ; Chorilli, Marlus; Marchetti, Juliana Maldonado
Source: Materials Science and Engineering C. Unidade: FCFRP
Subjects: NEOPLASIAS CEREBRAIS, ÁCIDO FÓLICO, NANOTECNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUIZ, Marcela Tavares et al. Docetaxel-loaded folate-modified TPGS-transfersomes for glioblastoma multiforme treatment. Materials Science and Engineering C, v. 124, p. 1-11, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.msec.2021.112033. Acesso em: 27 nov. 2025.
APA
Luiz, M. T., Viegas, J. S. R., Abriata, J. P., Tofani, L. B., Vaidergorn, M. de M., Emery, F. da S., et al. (2021). Docetaxel-loaded folate-modified TPGS-transfersomes for glioblastoma multiforme treatment. Materials Science and Engineering C, 124, 1-11. doi:10.1016/j.msec.2021.112033
NLM
Luiz MT, Viegas JSR, Abriata JP, Tofani LB, Vaidergorn M de M, Emery F da S, Chorilli M, Marchetti JM. Docetaxel-loaded folate-modified TPGS-transfersomes for glioblastoma multiforme treatment [Internet]. Materials Science and Engineering C. 2021 ; 124 1-11.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.msec.2021.112033
Vancouver
Luiz MT, Viegas JSR, Abriata JP, Tofani LB, Vaidergorn M de M, Emery F da S, Chorilli M, Marchetti JM. Docetaxel-loaded folate-modified TPGS-transfersomes for glioblastoma multiforme treatment [Internet]. Materials Science and Engineering C. 2021 ; 124 1-11.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.msec.2021.112033
Artigo de periodico
Synthesis and structure−activity relationships of imidazopyridine/pyrimidine- and furopyridine‐based anti‐infective agents against Trypanosomiases (2021)
Silva, Daniel G.; Junker, Anna; Melo, Shaiani Maria Gil de ; Fumagalli, Fernando; Gillespie, J. Robert; Molasky, Nora; Buckner, Frederick S.; Matheeussen, An; Caljon, Guy; Maes, Louis; Emery, Flavio da Silva
Source: ChemMedChem. Unidade: FCFRP
Subjects: TRIPANOSSOMICIDAS, ANTI-INFECCIOSOS, COMPOSTOS HETEROCÍCLICOS, DOENÇAS NEGLIGENCIADAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Daniel G. et al. Synthesis and structure−activity relationships of imidazopyridine/pyrimidine- and furopyridine‐based anti‐infective agents against Trypanosomiases. ChemMedChem, v. 16, n. 6, p. 966-975, 2021Tradução . . Disponível em: https://doi.org/10.1002/cmdc.202000616. Acesso em: 27 nov. 2025.
APA
Silva, D. G., Junker, A., Melo, S. M. G. de, Fumagalli, F., Gillespie, J. R., Molasky, N., et al. (2021). Synthesis and structure−activity relationships of imidazopyridine/pyrimidine- and furopyridine‐based anti‐infective agents against Trypanosomiases. ChemMedChem, 16( 6), 966-975. doi:10.1002/cmdc.202000616
NLM
Silva DG, Junker A, Melo SMG de, Fumagalli F, Gillespie JR, Molasky N, Buckner FS, Matheeussen A, Caljon G, Maes L, Emery F da S. Synthesis and structure−activity relationships of imidazopyridine/pyrimidine- and furopyridine‐based anti‐infective agents against Trypanosomiases [Internet]. ChemMedChem. 2021 ; 16( 6): 966-975.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1002/cmdc.202000616
Vancouver
Silva DG, Junker A, Melo SMG de, Fumagalli F, Gillespie JR, Molasky N, Buckner FS, Matheeussen A, Caljon G, Maes L, Emery F da S. Synthesis and structure−activity relationships of imidazopyridine/pyrimidine- and furopyridine‐based anti‐infective agents against Trypanosomiases [Internet]. ChemMedChem. 2021 ; 16( 6): 966-975.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1002/cmdc.202000616
Artigo de periodico
Parasitic sirtuin 2 as an opportunity in drug discovery (2021)
Gomes, Renan Augusto ; Fornari, Evelin; Rocha, Ana Carolina Silva; Tripodi, Gustavo Luis; Emery, Flavio da Silva ; Trossini, Gustavo Henrique Goulart
Source: Future Medicinal Chemistry. Unidades: FCFRP, FCF
Subjects: ANTIPROTOZOÁRIOS, EPIGÊNESE GENÉTICA, DOENÇAS INFECCIOSAS, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Renan Augusto et al. Parasitic sirtuin 2 as an opportunity in drug discovery. Future Medicinal Chemistry, v. 13, n. 16, p. 1397-1409, 2021Tradução . . Disponível em: https://doi.org/10.4155/fmc-2021-0091. Acesso em: 27 nov. 2025.
APA
Gomes, R. A., Fornari, E., Rocha, A. C. S., Tripodi, G. L., Emery, F. da S., & Trossini, G. H. G. (2021). Parasitic sirtuin 2 as an opportunity in drug discovery. Future Medicinal Chemistry, 13( 16), 1397-1409. doi:10.4155/fmc-2021-0091
NLM
Gomes RA, Fornari E, Rocha ACS, Tripodi GL, Emery F da S, Trossini GHG. Parasitic sirtuin 2 as an opportunity in drug discovery [Internet]. Future Medicinal Chemistry. 2021 ; 13( 16): 1397-1409.[citado 2025 nov. 27 ] Available from: https://doi.org/10.4155/fmc-2021-0091
Vancouver
Gomes RA, Fornari E, Rocha ACS, Tripodi GL, Emery F da S, Trossini GHG. Parasitic sirtuin 2 as an opportunity in drug discovery [Internet]. Future Medicinal Chemistry. 2021 ; 13( 16): 1397-1409.[citado 2025 nov. 27 ] Available from: https://doi.org/10.4155/fmc-2021-0091
Artigo de periodico
Insights into newly approved drugs from a medicinal chemistry perspective (2021)
Lima, Elys Juliane Cardoso ; Gomes, Renan Augusto ; Fornari, Evelin; Emery, Flavio da Silva ; Trossini, Gustavo Henrique Goulart
Source: Mini-Reviews in Medicinal Chemistry. Unidades: FCFRP, FCF
Assunto: FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Elys Juliane Cardoso et al. Insights into newly approved drugs from a medicinal chemistry perspective. Mini-Reviews in Medicinal Chemistry, v. 21, n. 16, p. 2227-2248, 2021Tradução . . Disponível em: https://doi.org/10.2174/1389557521666210226145328. Acesso em: 27 nov. 2025.
APA
Lima, E. J. C., Gomes, R. A., Fornari, E., Emery, F. da S., & Trossini, G. H. G. (2021). Insights into newly approved drugs from a medicinal chemistry perspective. Mini-Reviews in Medicinal Chemistry, 21( 16), 2227-2248. doi:10.2174/1389557521666210226145328
NLM
Lima EJC, Gomes RA, Fornari E, Emery F da S, Trossini GHG. Insights into newly approved drugs from a medicinal chemistry perspective [Internet]. Mini-Reviews in Medicinal Chemistry. 2021 ; 21( 16): 2227-2248.[citado 2025 nov. 27 ] Available from: https://doi.org/10.2174/1389557521666210226145328
Vancouver
Lima EJC, Gomes RA, Fornari E, Emery F da S, Trossini GHG. Insights into newly approved drugs from a medicinal chemistry perspective [Internet]. Mini-Reviews in Medicinal Chemistry. 2021 ; 21( 16): 2227-2248.[citado 2025 nov. 27 ] Available from: https://doi.org/10.2174/1389557521666210226145328
Artigo de periodico
Development of novel isoindolone-based compounds against Trypanosoma brucei rhodesiense (2021)
Silva, Daniel G.; Feijens, Pim Bart; Hendrickx, Rik; Matheeussen, An; Grey, Lucie; Caljon, Guy; Maes, Louis; Emery, Flavio da Silva ; Junker, Anna
Source: Chemistry Open. Unidade: FCFRP
Subjects: ANTI-INFECCIOSOS, TRYPANOSOMA, DOENÇAS TROPICAIS ANIMAL, SAÚDE PÚBLICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Daniel G. et al. Development of novel isoindolone-based compounds against Trypanosoma brucei rhodesiense. Chemistry Open, v. 10, n. 9, p. 922-927, 2021Tradução . . Disponível em: https://doi.org/10.1002/open.202100180. Acesso em: 27 nov. 2025.
APA
Silva, D. G., Feijens, P. B., Hendrickx, R., Matheeussen, A., Grey, L., Caljon, G., et al. (2021). Development of novel isoindolone-based compounds against Trypanosoma brucei rhodesiense. Chemistry Open, 10( 9), 922-927. doi:10.1002/open.202100180
NLM
Silva DG, Feijens PB, Hendrickx R, Matheeussen A, Grey L, Caljon G, Maes L, Emery F da S, Junker A. Development of novel isoindolone-based compounds against Trypanosoma brucei rhodesiense [Internet]. Chemistry Open. 2021 ; 10( 9): 922-927.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1002/open.202100180
Vancouver
Silva DG, Feijens PB, Hendrickx R, Matheeussen A, Grey L, Caljon G, Maes L, Emery F da S, Junker A. Development of novel isoindolone-based compounds against Trypanosoma brucei rhodesiense [Internet]. Chemistry Open. 2021 ; 10( 9): 922-927.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1002/open.202100180
Artigo de periodico
Structural basis for the function and inhibition of dihydroorotate dehydrogenase from Schistosoma mansoni (2021)
Mori, Renan Minin de ; Aleixo, Mariana Araújo Ajalla; Zapata, Luana Carlos Campisano ; Calil, Felipe A.; Emery, Flavio da Silva ; Nonato, Maria Cristina
Source: The FEBS Journal. Unidade: FCFRP
Subjects: SCHISTOSOMA MANSONI, ESQUISTOSSOMOSE, FÁRMACOS, ANTI-HELMÍNTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORI, Renan Minin de et al. Structural basis for the function and inhibition of dihydroorotate dehydrogenase from Schistosoma mansoni. The FEBS Journal, v. 288, n. 3, p. 930-944, 2021Tradução . . Disponível em: https://doi.org/10.1111/febs.15367. Acesso em: 27 nov. 2025.
APA
Mori, R. M. de, Aleixo, M. A. A., Zapata, L. C. C., Calil, F. A., Emery, F. da S., & Nonato, M. C. (2021). Structural basis for the function and inhibition of dihydroorotate dehydrogenase from Schistosoma mansoni. The FEBS Journal, 288( 3), 930-944. doi:10.1111/febs.15367
NLM
Mori RM de, Aleixo MAA, Zapata LCC, Calil FA, Emery F da S, Nonato MC. Structural basis for the function and inhibition of dihydroorotate dehydrogenase from Schistosoma mansoni [Internet]. The FEBS Journal. 2021 ; 288( 3): 930-944.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1111/febs.15367
Vancouver
Mori RM de, Aleixo MAA, Zapata LCC, Calil FA, Emery F da S, Nonato MC. Structural basis for the function and inhibition of dihydroorotate dehydrogenase from Schistosoma mansoni [Internet]. The FEBS Journal. 2021 ; 288( 3): 930-944.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1111/febs.15367
Artigo de periodico
Decitabine promotes modulation in phenotype and function of monocytes and macrophages that drive immune response regulation (2021)
Zambuzi, Fabiana Albani ; Silva, Priscilla Mariane Cardoso; Castro, Ricardo Cardoso ; Fontanari, Caroline ; Emery, Flavio da Silva ; Frantz, Fabiani Gai
Source: Cells. Unidades: FCFRP, FMRP
Subjects: FAGOCITOSE, MONÓCITOS, MACRÓFAGOS, ADJUVANTES IMUNOLÓGICOS, SISTEMA IMUNE, IMUNOLOGIA, FENÓTIPOS, DOENÇAS INFECCIOSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZAMBUZI, Fabiana Albani et al. Decitabine promotes modulation in phenotype and function of monocytes and macrophages that drive immune response regulation. Cells, v. 10, n. 4, p. 1-16, 2021Tradução . . Disponível em: https://doi.org/10.3390/cells10040868. Acesso em: 27 nov. 2025.
APA
Zambuzi, F. A., Silva, P. M. C., Castro, R. C., Fontanari, C., Emery, F. da S., & Frantz, F. G. (2021). Decitabine promotes modulation in phenotype and function of monocytes and macrophages that drive immune response regulation. Cells, 10( 4), 1-16. doi:10.3390/cells10040868
NLM
Zambuzi FA, Silva PMC, Castro RC, Fontanari C, Emery F da S, Frantz FG. Decitabine promotes modulation in phenotype and function of monocytes and macrophages that drive immune response regulation [Internet]. Cells. 2021 ; 10( 4): 1-16.[citado 2025 nov. 27 ] Available from: https://doi.org/10.3390/cells10040868
Vancouver
Zambuzi FA, Silva PMC, Castro RC, Fontanari C, Emery F da S, Frantz FG. Decitabine promotes modulation in phenotype and function of monocytes and macrophages that drive immune response regulation [Internet]. Cells. 2021 ; 10( 4): 1-16.[citado 2025 nov. 27 ] Available from: https://doi.org/10.3390/cells10040868
Artigo de periodico
Impact of the arylation of fused N-bridged BODIPY dyes in photophysical properties (2021)
Mello, Rodrigo Brito de ; Emery, Flavio da Silva
Source: Journal of Fluorescence. Unidade: FCFRP
Subjects: CORANTES, QUÍMICA ORGÂNICA, COMPOSTOS ORGÂNICOS, SISTEMA QUÂNTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MELLO, Rodrigo Brito de e EMERY, Flavio da Silva. Impact of the arylation of fused N-bridged BODIPY dyes in photophysical properties. Journal of Fluorescence, v. 32, n. 1, p. 81-86, 2021Tradução . . Disponível em: https://doi.org/10.1007/s10895-021-02831-z. Acesso em: 27 nov. 2025.
APA
Mello, R. B. de, & Emery, F. da S. (2021). Impact of the arylation of fused N-bridged BODIPY dyes in photophysical properties. Journal of Fluorescence, 32( 1), 81-86. doi:10.1007/s10895-021-02831-z
NLM
Mello RB de, Emery F da S. Impact of the arylation of fused N-bridged BODIPY dyes in photophysical properties [Internet]. Journal of Fluorescence. 2021 ; 32( 1): 81-86.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1007/s10895-021-02831-z
Vancouver
Mello RB de, Emery F da S. Impact of the arylation of fused N-bridged BODIPY dyes in photophysical properties [Internet]. Journal of Fluorescence. 2021 ; 32( 1): 81-86.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1007/s10895-021-02831-z

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Grupo de pesquisa

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration